<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03113253</url>
  </required_header>
  <id_info>
    <org_study_id>2016-06</org_study_id>
    <nct_id>NCT03113253</nct_id>
  </id_info>
  <brief_title>TRANexamic Acid to Reduce Bleeding in BURN Surgery</brief_title>
  <acronym>TRANBURN</acronym>
  <official_title>The Effect of Tranexamic Acid (TXA) on Blood Loss in Burn Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Saint Joseph Saint Luc de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société Française d'Anesthésie et de Réanimation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Saint Joseph Saint Luc de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Excision and grafting in burn patients can lead to severe blood loss. A preliminary study
      conducted in our burn unit showed that the total median blood loss was 1412 mL (1).
      Transfused patients had a total median blood loss of 2468 mL and an average number of 4
      packed red blood cells (PRBC) administered.

      Among the various methods that help limit blood loss, tranexamic acid, which has been proved
      useful in traumatology and surgery, has not been sufficiently studied in burn patients. A
      preliminary study in 27 burned patients showed a reduction of blood loss with tranexamic acid
      (2).

      Objective of TRANBURN study is to demonstrate that tranexamic acid help limit blood loss and
      reduces the use of blood products.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The first aim of the study is to demonstrate that tranexamic acid help limit blood loss and
      reduces the use of blood products.

      Secondary objectives are to evaluate impact of tranexamic acid on mortality, success of skin
      grafts and occurrence of deep vein thrombosis or myocardial infarction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss (mL / cm² excised)</measure>
    <time_frame>Until day 5 post surgery</time_frame>
    <description>To determine the impact of tranexamic acid on blood loss in burn surgeries</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for transfusion</measure>
    <time_frame>Until day 5 post surgery</time_frame>
    <description>Number of blood product transfused</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause Hospital Mortality</measure>
    <time_frame>Until day 15 post surgery</time_frame>
    <description>Any death during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success of skin graft</measure>
    <time_frame>Until day 15 post surgery</time_frame>
    <description>Number of successful skin graft</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep vein thrombosis</measure>
    <time_frame>Until day 15 post surgery</time_frame>
    <description>Number of deep vein thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>Until day 15 post surgery</time_frame>
    <description>Number of myocardial infarctions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>Until day 15 post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary embolism</measure>
    <time_frame>Until day 15 post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Convulsion</measure>
    <time_frame>Until day 15 post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Tranexamic Acid</condition>
  <condition>Burns</condition>
  <condition>Surgery</condition>
  <condition>Wounds and Injuries</condition>
  <arm_group>
    <arm_group_label>Tranexamic Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive:
1g of tranexamic acid by slow intravenous injection
1g of tranexamic acid by syringe pump during 8 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient will receive:
10 mL of 0.9% sodium chloride by slow intravenous injection
48 mL of 0.9% sodium chloride by syringe pump during 8 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <arm_group_label>Tranexamic Acid</arm_group_label>
    <other_name>Exacyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>0.9% sodium chloride to mimic tranexamic acid</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>0.9% sodium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects undergoing burn excision surgery for standard of care purposes

          -  Male or female &gt;= 18 years of age

          -  Subject or subject's medical decision maker agrees to participate in this study and
             provides informed consent

        Exclusion Criteria:

          -  Subjects with a history of hypercoagulopathy, deep vein thrombosis (DVT), pulmonary
             embolism

          -  Renal impairment

          -  Subjects with known hypersensitivity to tranexamic acid

          -  Consecutive fibrinolytic states to coagulopathy

          -  History of convulsions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu Fontaine, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Joseph Saint Luc Hospital, Burn Intensive Care Unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu Fontaine</last_name>
    <phone>+33478618945</phone>
    <email>brules@ch-stjoseph-stluc-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Commun de Traitement des Brûlés - Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Rimmelé, MD, PhD</last_name>
      <phone>+33472116988</phone>
      <email>thomas.rimmele@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Saint Joseph Saint Luc</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Rio</last_name>
      <phone>+33478618216</phone>
      <email>srio@ch-stjoseph-stluc-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Mathieu Fontaine, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>François Ravat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques Latarjet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine Voulliaume, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline Payre, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Charles Poupelin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.ch-stjoseph-stluc-lyon.fr/sp%C3%A9cialit%C3%A9s/4.Recherche%20clinique/</url>
    <description>Saint Joseph Saint Luc Hospital</description>
  </link>
  <reference>
    <citation>Farny B, Fontaine M, Payre J, Ravat F, Poupelin J-C, Latarjet J. Évaluation des pertes sanguines lors des chirurgies d'excision-autogreffe de peau chez les patients brûlés. Anesthésie &amp; Réanimation. 2015;1:A307‑8.</citation>
  </reference>
  <reference>
    <citation>Jennes S, Degrave E, Despiegeleer X, Grenez O. Effect of Tranexamic Acid on Blood Loss in Burn Surgery: A Preliminary Study. Journal of Burn Care &amp; Rehabilitation. 2003;24:S59.</citation>
  </reference>
  <reference>
    <citation>Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin. 1996;13(8):465-78.</citation>
    <PMID>9010613</PMID>
  </reference>
  <reference>
    <citation>Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012 May 17;344:e3054. doi: 10.1136/bmj.e3054. Review.</citation>
    <PMID>22611164</PMID>
  </reference>
  <reference>
    <citation>Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006 Nov;105(5):1034-46. Review.</citation>
    <PMID>17065899</PMID>
  </reference>
  <reference>
    <citation>CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14.</citation>
    <PMID>20554319</PMID>
  </reference>
  <reference>
    <citation>Desai MH, Herndon DN, Broemeling L, Barrow RE, Nichols RJ Jr, Rutan RL. Early burn wound excision significantly reduces blood loss. Ann Surg. 1990 Jun;211(6):753-9; discussion 759-62.</citation>
    <PMID>2357138</PMID>
  </reference>
  <reference>
    <citation>Curinga G, Jain A, Feldman M, Prosciak M, Phillips B, Milner S. Red blood cell transfusion following burn. Burns. 2011 Aug;37(5):742-52. doi: 10.1016/j.burns.2011.01.016. Epub 2011 Mar 1. Review.</citation>
    <PMID>21367529</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tranexamic Acid</keyword>
  <keyword>Burn</keyword>
  <keyword>Surgery</keyword>
  <keyword>Excision</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

